幼年特发性关节炎治疗的观点问题
被引量：2
Viewpoint of Therapy of Juvenile Idiopathic Arthritis
摘要
近10a,伴随发病机制的深入研究和以机制中的环节为治疗靶点的药物开发与应用,儿童特发性关节炎/幼年类风湿性关节炎的疾病缓解率逐年提高。窗口期早期控制的概念引导传统药物与生物制剂联合治疗将是未来的趋势。
出处
《实用儿科临床杂志》
CAS
CSCD
北大核心
2009年第21期1628-1631,共4页
Journal of Applied Clinical Pediatrics
参考文献22
-
1Packham JC, Hall MA. Long - term follow - up of 246 adults with juvenile idiopathic arthritis : Functional outcome [ J ]. Rheumatology ( Oxford) ,2002,41 (12) :1428 - 1435.
-
2McCann LJ, Wedderburn LR, Hasson H. Best Practice:Juvenile idiopalhic arthritis [ J 1. A rch Dis Child,2006, 91:29 - 36.
-
3McCann I J, Woo P. BioLogic therapies in juvenile idiopathic arthritis: Why and for whom[J ]? Acta Reum Port,2007,32 ( 1 ) : 15 - 26.
-
4Takken T, van Bmssel M, Engelbert RH, et al. Exercise therapy in juvenile idiopathic arthritis : A Cochrane review [ J ]. Eur J Phyc Rehabil Med ,2008,44 ( 3 ) :287 - 297.
-
5Wallace CA, Ravelli A, Huang B ,et al. Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis [ J ]. J Rheumatol,2006,33 (4) :789 - 795.
-
6Reiff A, Lovell D J, Adelsberg JV, et al. Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: A 12 - week randomized controlled clinical trial with a 52 - week open - label extension[ J]. J Rheumatol,2006,33 (5) :985 - 995.
-
7Puperton N, Nikishina I, Pachanov ED, et al. A randomized, double blind, clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis[ J]. Arthritis Rheum,2005,52 (2) :563 -572.
-
8Arabshahi B, Dewitt EM, Cahill AM. et al. Utility of corticosteroid injection for temporomandibular arthritis in children with juvenile idiopathic arthritis [ J ]. Arthritis Rheum,2005,52 ( 11 ) :3563 - 3569.
-
9Fruchter O, Kino T, Zoumakis E, et al. The human glucocorticoid receptor(GR) isoformβ differentially suppresses GRα- induced transactivation stimulated by synthetic glucocorticoids [ J ]. J Clin Endocrinol Metab, 2005,90 ( 6 ) : 3505 - 3509.
-
10Giaunini EH, Brewer EJ, Kuzmina N, et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the USA - URSS double - blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and the Cooperative Children's Study Group[ J]. N Engl J Med, 1992,326 : 1043 - 1049.
同被引文献33
-
1李亚琴,曹兰芳.肾上腺糖皮质激素在幼年特发性关节炎中的应用进展[J].中国当代儿科杂志,2009,11(3):240-242. 被引量：4
-
2周国平.幼年特发性关节炎的诊断与治疗现状[J].实用儿科临床杂志,2009,24(9):717-720. 被引量：9
-
3刘曦,刘爱京,邵福灵.沙利度胺治疗风湿性疾病机制的研究进展[J].中华风湿病学杂志,2006,10(6):366-368. 被引量：19
-
4Ravelli A, Martini A. Juvenile idiopathic arthritis [ J ]. Lancet, 2007, 369 (9563) : 767 - 778.
-
5Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis : Durban, 1997 [J]. J Rheumatol,1998,25( 10): 1991 - 1994.
-
6Foeldvari I, Bidde M. Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for Rheumatology[ J ]. J Rheumatol, 2000,27 ( 4 ) : 1069 - 1072.
-
7胡亚美,江载芳.幼年类风湿性关节炎[M].第7版.实用儿科学,北京:人民卫生出版社,2002.670.
-
8McCann LJ, Wedderburn LR, Hasson H. Best Practice: Juvenile idiopathic arthritis [ J ]. Arch Dis Child,2006,91 : 29 - 36.
-
9Reiff A, Lovell D J, Adelsberg JV. Evaluation of the comparative efficacy and tolerability of rofecoxib and nap roxen in children and adolescents with juvenile rheumatoid arthritis: A12-week randomized controlled clinical trialwith a 52-week open-label extension [ J ]. J Rheumatol,2006,33 ( 5 ) : 985 - 995.
-
10Puperton N, Nikishina I, Pachanov ED. A randomized, double blind, clinical trim of two doses of meloxicam compared with nap roxen in children with juvenile idiopathic arthritis [ J ]. Arthritis Rheum,2005, 52(2) : 563 -572.
二级引证文献8
-
1邹晋梅,杨静,邓代华.沙利度胺联合来氟米特与甲氨蝶呤治疗类风湿关节炎的疗效观察[J].当代医学,2012,18(16):58-60. 被引量：21
-
2李迪,张小飞,魏岚,赵学良.幽门螺杆菌感染与幼年特发性关节炎关系的探讨[J].吉林医学,2013,34(12):2241-2242.
-
3李海洋,吴中婷,周红梅.血管生成在口腔扁平苔藓发生发展中的作用[J].临床口腔医学杂志,2013,29(5):308-309.
-
4韩彤昕,李彩凤,王江,邝伟英,周怡芳,邓江红.麦考酚酸酯治疗幼年特发性关节炎全身型的疗效分析[J].中国当代儿科杂志,2013,15(8):666-670. 被引量：2
-
5尹薇,刘凡,谢彤,丁艳.降钙素原在幼年特发性关节炎中的表达[J].中国妇幼保健,2014,29(10):1564-1567. 被引量：2
-
6许志有,李学广,董战玲.PCT联合hs-CRP对幼年特发性关节炎的诊断价值[J].中国热带医学,2015,15(10):1249-1250.
-
7谢婷,孙华君,李志玲,刘红霞.沙利度胺在儿童风湿性疾病应用的安全性[J].儿科药学杂志,2023,29(5):6-10.
-
8陈新,房军臣,郭敬肖,葛兰兰,刘福娟,韩佩桐,刘玲.沙利度胺治疗难治性全身型幼年特发性关节炎的疗效分析[J].国际儿科学杂志,2024,51(2):132-137.
-
1吴小川,彭晓杰,张国珍.幼年特发性关节炎治疗进展[J].实用儿科临床杂志,2007,22(9):718-720. 被引量：5
-
2李波,蒋红雨,艾戎.幼年特发性关节炎并巨噬细胞活化综合征2例[J].实用儿科临床杂志,2008,23(3):172-172. 被引量：1
-
3张帆,闫会丽.布地奈德和沙丁胺醇联合雾化吸入治疗毛细支气管炎的疗效观察[J].实用全科医学,2007,5(8):666-667. 被引量：8
-
4吴胜伟,韦柳春.氨溴索氧驱动雾化治疗婴幼儿支气管肺炎对比观察[J].华夏医学,2009,22(1):52-53.
-
5宋康文,杨钊,卓平辉.蓝光照射治疗新生儿黄疸的临床疗效分析[J].吉林医学,2010,31(33):5989-5989. 被引量：4
-
6李慧.新生儿黄疸光疗法疗效分析[J].医学信息,2013(8):179-179.
-
7刘文彬,王太森,袁丽,刘华君.沐舒坦氧驱动雾化吸入佐治婴儿毛细支气管炎效果分析[J].四川医学,2012,33(3):417-418. 被引量：6
-
8向娟.光疗法治疗新生儿黄疸疗效观察[J].临床合理用药杂志,2012,5(4):50-51. 被引量：3
-
9薛海燕,曹兰芳,马敏,卢燕鸣,毛海英,顾越英.激素治疗难治性全身型幼年特发性关节炎39例[J].实用儿科临床杂志,2007,22(9):678-679. 被引量：4
-
10徐小改,荆华.幼年特发性关节炎患者的护理干预[J].山西医药杂志,2014,43(21):2596-2597.
